NCT02331277View on ClinicalTrials.gov

Safety and Pharmacokinetics of Multiple Doses of BI 655064 in Healthy Chinese Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

May 25, 2016

Study Completion Date

May 25, 2016

Conditions
Healthy
Interventions
DRUG

BI 655064

subcutaneous injection

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

1293.9.8201 Boehringer Ingelheim Investigational Site, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY